Breanna Fields

• In re Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL 3094 (E.D. Pa.): National counsel for Novo Nordisk in MDL and related state court litigation
• In re Covidien Hernia Mesh Products Liability Litigation No. II, MDL 3029 (D. Mass.): National counsel for Medtronic in products liability litigation regarding Covidien hernia mesh devices
• In re Proton Pump Inhibitor Products Liability Litigation (II), MDL 2789 (D.N.J.): National counsel for Pfizer and Wyeth in product liability litigation alleging that proton pump inhibitors Protonix cause chronic kidney disease and other kidney injuries
• Essure Product Liability Litigation: Counsel for Bayer in product liability litigation alleging injuries caused by permanent contraceptive device
• In re Incretin Mimetics Products Liability Litigation, MDL 2452 (S.D. Cal.): National counsel for Novo Nordisk Inc. in product liability litigation alleging that Victoza cause pancreatic cancer resulting in summary judgment in favor of defense

Before joining DLA Piper, Breanna was a litigation associate in a New York-based international law firm. In her role as a litigation associate, Breanna represented both private companies and public corporations in wide-ranging litigations in both state and federal courts, with a focus on complex commercial and securities litigation.

During law school, Breanna externed for the Honorable Laura Taylor Swain, United States District Court for the Southern District of New York. She also gained significant litigation experience during her externship with the Center for Appellate Litigation in New York, where she successfully argued an appellate brief in state court.